ArticleParasite (Paris, France)2020
A clioquinol-containing Pluronic
Open access · goldAbstract read
In one paragraph
Article in Parasite (Paris, France), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 30 citations in OpenAlex.
- Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral Leishmaniasis.Pathogens (Basel, Switzerland) · 2025Article
- Article
- Application of nano and microformulations to improve the leishmanicidal response of quinoline compounds: a brief review.Frontiers in chemistry · 2025Review
- Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.Cancer reports (Hoboken, N.J.) · 2024Review
- Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis.Pharmaceutics · 2023Article
- High Selectivity of 8-Hydroxyquinoline onPharmaceuticals (Basel, Switzerland) · 2023Article
- Development of a Clioquinol Nanocarrier as a New, Promising Option for the Treatment of Dermatomycosis.Pharmaceutics · 2023Article
- Immunogenicity and protective efficacy of tuzin protein as a vaccine candidate inFrontiers in immunology · 2023Article
- Antimicrobial activity of clioquinol and nitroxoline: a scoping review.Archives of microbiology · 2022Article
- Parasitological and immunological evaluation of a quinoline derivative salt incorporated into a polymeric micelle formulation against Leishmania infantum infection.Parasitology research · 2022Article
- Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.Medical microbiology and immunology · 2021Article
- Nano- and Microformulations to Advance Therapies for Visceral Leishmaniasis.ACS biomaterials science & engineering · 2021Review
- Article
- Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.Parasitology research · 2021Article
- In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis.Parasite (Paris, France) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 3 institutions in 2 countries.
Grasiele S V TavaresMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Débora V C MendonçaMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Isabela A G PereiraMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
João A Oliveira-da-SilvaMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Fernanda F RamosMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Daniela P LageMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Amanda S MachadoMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Lívia M CarvalhoDepartamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil.
Thiago A R ReisMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Luísa PerinMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Ana Maria R S CarvalhoMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Flaviano M OttoniLaboratório de Imunopatologia, Núcleo de Pesquisas em Ciências Biológicas/NUPEB, Departamento de Ciências Biológicas, Insituto de Ciências Exatas e Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil.
Fernanda LudolfMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Camila S FreitasMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Raquel S BandeiraMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Alessandra M SilvaMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Miguel A Chávez-FumagalliUniversidad Católica de Santa María, Urb. San José S/N, Umacollo, Arequipa, Peru.
Mariana C DuarteMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil - Departamento de Patologia Clínica, COLTEC, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Daniel Menezes-SouzaMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil - Departamento de Patologia Clínica, COLTEC, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Ricardo J AlvesLaboratório de Imunopatologia, Núcleo de Pesquisas em Ciências Biológicas/NUPEB, Departamento de Ciências Biológicas, Insituto de Ciências Exatas e Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil.
Bruno M RoattDepartamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil.
Eduardo A F CoelhoMedicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil - Departamento de Patologia Clínica, COLTEC, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Universidade Federal de Minas Gerais · BRUniversidade Federal de Ouro Preto · BRCatholic University of Santa María · PE
Funding
No grant is acknowledged in the PubMed record.
Abstract
A clioquinol (ICHQ)-containing Pluronic
Indexed as
MicellesAnimalsAntibodies, ProtozoanClioquinolCytokinesDisease Models, AnimalDrug Delivery SystemsFemaleLeishmania infantumLeishmaniasis, VisceralMiceMice, Inbred BALB CParasite LoadPoloxamerTh1 CellsAntibodies, ProtozoanClioquinolCytokinesMicellesPoloxamerClioquinolDelivery systemsImmune responseMiltefosineTreatmentVisceral leishmaniasis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.